Advancements in the treatment of malignancies using a combination of immune checkpoint inhibitors and immunomodulators
10.3969/j.issn.1005-6483.2024.01.025
- VernacularTitle:免疫检查点抑制剂联合免疫增强剂治疗恶性肿瘤的研究进展
- Author:
Ronghua ZHU
1
;
Zhiyong HUANG
Author Information
1. 430030 武汉,华中科技大学同济医学院附属同济医院肝脏外科中心
- Keywords:
malignant tumors;
immunotherapy;
immune checkpoint inhibitors;
immunomodulators;
combination therapy
- From:
Journal of Clinical Surgery
2024;32(1):92-95
- CountryChina
- Language:Chinese
-
Abstract:
In recent years,there have been significant advancements in tumor immunotherapy.Immune checkpoint inhibitors have emerged as a pivotal approach for treating advanced malignant tumors.The use of immunotherapy has been widely recommended and applied in clinical treatment both domestically and internationally.However,its clinical treatment efficacy still falls short of expectations.Improving the efficacy of immunotherapy for patients with advanced malignant tumors is currently a prominent research focus.Studies indicate that the combined use of immune enhancers and immune checkpoint inhibitors in various advanced malignant tumors significantly enhances the outcomes of immunotherapy.This article primarily highlights the combined application of immune enhancers and immune checkpoint inhibitors in cancer therapy,offering insights into their potential in the field of oncology treatment.
